AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Brookdale Senior Living Inc.

Regulatory Filings Nov 17, 2022

Preview not available for this file type.

Download Source File

FWP 1 d422796dfwp.htm FWP FWP

Filed pursuant to Rule 433

Dated November 16, 2022

Issuer Free Writing Prospectus supplementing the

Preliminary Prospectus Supplement

dated November 16, 2022 and the

Prospectus dated November 16, 2022

Registration No. 333-268404

Brookdale Senior Living Inc.

Offering of

2,500,000 7.00% Tangible Equity Units

(the “Units Offering”)

The information in this pricing term sheet relates only to the Units Offering and should be read together with (i) the preliminary prospectus supplement, dated November 16, 2022 (the “ Preliminary Prospectus Supplement ”), as filed with the Securities and Exchange Commission (the “ SEC ”) pursuant to Rule 424(b) under the Securities Act of 1933, as amended, and (ii) the related base prospectus dated November 16, 2022 included in the Registration Statement (File No. 333-268404), in each case, including the documents incorporated by reference therein. Terms used but not defined herein have the meanings assigned to such terms in the Preliminary Prospectus Supplement.

Issuer: Brookdale Senior Living Inc., a Delaware corporation.
Ticker / Exchange for Common Stock: BKD/New York Stock Exchange (“ NYSE ”)
Pricing Date: November 16, 2022.
Settlement Date: November 21, 2022.
Last Reported Sale Price of the Common Stock on the NYSE on the Pricing Date: $3.29
Title of Securities: 7.00% Tangible Equity Units (the “ Units ”).
Number of Units Offered: 2,500,000 Units (or 2,875,000 Units if the underwriters exercise their over-allotment option to purchase additional Units in full).
Stated Amount: Each Unit has a stated amount of $50.00.
Composition of Units: Each Unit is comprised of two parts: •  a prepaid stock purchase contract issued by Issuer (a “ Purchase Contract ”);
and •  a senior amortizing
note issued by Issuer (an “ Amortizing Note ”), which has an initial principal amount of $8.8996 per Amortizing Note, bears interest at a rate of 10.25% per annum and has a final installment payment date of November 15,
2025.
Fair Market Value of the Units: Issuer has determined that the fair market value of each Amortizing Note is $8.8996 and the fair market value of each Purchase Contract is $41.1004.
Reference Price: $50.00 divided by the Maximum Settlement Rate (rounded to the nearest $0.0001), which is initially approximately equal to the last reported sale price of Issuer’s Common Stock on the NYSE on the Pricing Date.
Threshold Appreciation Price: $50.00 divided by the Minimum Settlement Rate (rounded to the nearest $0.0001), which is initially approximately $3.87 and represents an approximately 17.50% appreciation over the Reference Price.
Minimum Settlement Rate: 12.9341 shares of Common Stock per Purchase Contract (subject to adjustment as described in the Preliminary Prospectus Supplement).
Maximum Settlement Rate: 15.1976 shares of Common Stock per Purchase Contract (subject to adjustment as described in the Preliminary Prospectus Supplement).
Settlement Rate: The following table illustrates the settlement rate per Purchase Contract and the value of Common Stock issuable upon settlement on the Mandatory Settlement Date, or in respect of any early settlement of a Purchase Contract at the
option of a holder as described under “Description of the Purchase Contracts—Early Settlement” in the Preliminary Prospectus Supplement (other than in connection with a fundamental change), determined using the “applicable market
value” (as defined in the Preliminary Prospectus Supplement) shown, subject to adjustment as described in the Preliminary Prospectus Supplement:

| Applicable Market Value of Common Stock | Settlement Rate | Value of Common Stock Delivered (Based on the Applicable
Market Value Thereof) |
| --- | --- | --- |
| Less than the Reference Price | The Maximum Settlement Rate | Less than $50.00 |
| Greater than or equal to the Reference Price but less than or equal to the Threshold Appreciation Price | A number of shares of Common Stock equal to $50.00, divided by the applicable market value | $50.00 |
| Greater than the Threshold Appreciation Price | The Minimum Settlement Rate | Greater than $50.00 |

2

Early Settlement at Holder’s Election:

Until 5:00 p.m., New York City time, on the second scheduled trading day immediately preceding November 15, 2025, a holder may settle any or all of its Purchase Contracts early only under the following circumstances:

• on or after February 15, 2023, on the second trading day immediately following the last trading day of any 20 consecutive trading day period during which the closing price of Common Stock has been greater than or equal to 110% of the Threshold Appreciation Price then in effect on each trading day in such 20 consecutive trading day period;

• on or after February 15, 2023, during the five business day period after any ten consecutive trading day period (the “measurement period”) in which (x) the “trading price” (as defined under “Description of the Purchase Contracts—Early Settlement” in the Preliminary Prospectus Supplement) per Unit for each trading day of the measurement period was less than 97% of the product of the closing price of Common Stock and the Maximum Settlement Rate on each such trading day and (y) the closing price of Common Stock on each trading day of the measurement period was less than 70% of the Reference Price; or

• upon the occurrence of specified corporate events as described under “Description of the Purchase Contracts—Early Settlement—Early Settlement upon Specified Corporate Events” in the Preliminary Prospectus Supplement.

If a holder elects to settle any or all of its Purchase Contracts early in accordance with the foregoing conditions, Issuer will deliver a number of shares of Common Stock for each such Purchase Contract based on the applicable Settlement Rate, unless such holder elects to settle its Purchase Contracts early in connection with a fundamental change, in which case such holder will receive upon settlement of such Purchase Contracts a number of shares of Common stock based on the fundamental change early settlement rate.

Upon early settlement at the holder’s election of a Purchase Contract that is a component of a Unit, the corresponding Amortizing Note will remain outstanding and beneficially owned by or registered in the name of, as the case may be, the holder who elected to settle the related Purchase Contract early.

Early Settlement Upon a Fundamental Change:

The following table sets forth the “fundamental change early settlement rate” (as defined in the Preliminary Prospectus Supplement) per Purchase Contract for each stock price and effective date set forth below:

Stock Price — Effective Date $1.50 $2.00 $2.50 $3.00 $3.29 $3.50 $3.87 $4.50 $5.00 $6.00 $8.00 $10.00 $20.00 $30.00
November 21, 2022 13.9308 13.5680 13.2984 13.1084 13.0266 12.9776 12.9090 12.8278 12.6680 12.6512 12.6648 12.6869 12.7305 12.7373
February 15, 2023 14.0349 13.6607 13.3741 13.1688 13.0795 13.0259 12.9506 12.8612 12.7016 12.6798 12.6893 12.7093 12.7480 12.7536
May 15, 2023 14.1442 13.7602 13.4557 13.2332 13.1356 13.0767 12.9939 12.8951 12.7358 12.7086 12.7138 12.7315 12.7652 12.7699
August 15, 2023 14.2548 13.8641 13.5413 13.3002 13.1934 13.1287 13.0374 12.9284 12.7693 12.7364 12.7374 12.7529 12.7817 12.7856
November 15, 2023 14.3742 13.9805 13.6381 13.3753 13.2575 13.1858 13.0844 12.9632 12.8042 12.7650 12.7614 12.7746 12.7985 12.8018
February 15, 2024 14.4981 14.1077 13.7454 13.4578 13.3269 13.2470 13.1336 12.9981 12.8390 12.7929 12.7850 12.7958 12.8151 12.8179
May 15, 2024 14.6249 14.2474 13.8660 13.5498 13.4032 13.3132 13.1851 13.0323 12.8730 12.8198 12.8078 12.8164 12.8314 12.8340
August 15, 2024 14.7490 14.3983 14.0012 13.6522 13.4866 13.3841 13.2379 13.0644 12.9047 12.8443 12.8290 12.8356 12.8473 12.8498
November 15, 2024 14.8699 14.5688 14.1635 13.7751 13.5843 13.4650 13.2943 13.0936 12.9335 12.8662 12.8493 12.8543 12.8635 12.8659
February 15, 2025 14.9746 14.7548 14.3612 13.9270 13.7014 13.5581 13.3523 13.1147 12.9548 12.8831 12.8678 12.8717 12.8796 12.8821
May 15, 2025 15.0472 14.9451 14.6134 14.1323 13.8538 13.6715 13.4084 13.1161 12.9601 12.8927 12.8846 12.8883 12.8957 12.8982
August 15, 2025 15.0792 15.0864 14.9306 14.4541 14.0856 13.8237 13.4406 13.0623 12.9328 12.8966 12.9001 12.9039 12.9114 12.9139
November 15, 2025 15.1976 15.1976 15.1976 15.1976 15.1976 14.2857 12.9341 12.9341 12.9341 12.9341 12.9341 12.9341 12.9341 12.9341

The exact stock prices and effective dates may not be set forth in the table above, in which case:

• if the applicable stock price is between two stock prices in the table or the applicable effective date is between two effective dates in the table, the fundamental change early settlement rate will be determined by straight line interpolation between the fundamental change early settlement rates set forth for the higher and lower stock prices and the earlier and later effective dates, as applicable, based on a 365- or 366-day year, as applicable;

3

• if the applicable stock price is greater than $30.00 per share (subject to adjustment in the same manner and at the same time as the stock prices set forth in the column headings of the table above), then the fundamental change early settlement rate will be the Minimum Settlement Rate; or

• if the applicable stock price is less than $1.50 per share (subject to adjustment in the same manner and at the same time as the stock prices set forth in the column headings of the table above, the “ Minimum Stock Price ”), the fundamental change early settlement rate will be determined as if the stock price equaled the Minimum Stock Price, and using straight line interpolation, as described in the first bullet of this paragraph, if the effective date is between two effective dates in the table.

The maximum number of shares of Common Stock deliverable under a Purchase Contract is 15.1976, subject to adjustment in the same manner and at the same time as the fixed settlement rates as set forth under “Description of the Purchase Contracts—Adjustments to the Fixed Settlement Rates” in the Preliminary Prospectus Supplement.

| Early Mandatory Settlement at Issuer’s Election: | Issuer has the right to settle the Purchase Contracts on or after November 15, 2023, in whole but not in part, on the second business day following Issuer’s giving notice of such election if the closing price of Common
Stock for 20 or more consecutive trading days ending on the second trading day immediately preceding the “notice date” (as defined under “Description of the Purchase Contracts—Early Settlement at Our Election” in the
Preliminary Prospectus Supplement) exceeds 130% of the Threshold Appreciation Price in effect on each such trading day. The “early mandatory settlement rate” will be the Settlement Rate that would apply as if the notice date was the
applicable early settlement date (as described in “Description of the Purchase Contracts—Delivery of Common Stock” and “Description of the Purchase Contracts—Early Settlement” in the Preliminary Prospectus
Supplement). |
| --- | --- |
| Initial Principal Amount of Amortizing Notes: | $8.8996 per Amortizing Note $22,249,000 in
aggregate (or $25,586,350 in the aggregate if the underwriters exercise their over-allotment option to purchase additional Units in full). |
| Installment Payment Dates: | Each February 15, May 15, August 15 and November 15, commencing on February 15, 2023, with a final installment payment date of November 15, 2025. |
| Payments on the Amortizing Notes: | The Amortizing Notes will pay holders quarterly cash installments of $0.8750 per Amortizing Note (except for the February 15, 2023 installment payment, which will be $0.8166 per Amortizing Note), which cash payment in the
aggregate will be equivalent to 7.00% per annum with respect to each $50 Stated Amount of Units. Each installment will constitute a payment of interest (at a rate of 10.25% per annum) and a partial repayment of principal on the Amortizing Note,
allocated as set forth in the following amortization schedule: |

4

Scheduled Installment Payment Date Amount of Principal Amount of Interest
February 15, 2023 $ 0.6038 $ 0.2128
May 15, 2023 $ 0.6624 $ 0.2126
August 15, 2023 $ 0.6794 $ 0.1956
November 15, 2023 $ 0.6968 $ 0.1782
February 15, 2024 $ 0.7147 $ 0.1603
May 15, 2024 $ 0.7330 $ 0.1420
August 15, 2024 $ 0.7518 $ 0.1232
November 15, 2024 $ 0.7710 $ 0.1040
February 15, 2025 $ 0.7908 $ 0.0842
May 15, 2025 $ 0.8110 $ 0.0640
August 15, 2025 $ 0.8318 $ 0.0432
November 15, 2025 $ 0.8531 $ 0.0219

| Repurchase of Amortizing Notes at the Option of the Holder: | If Issuer elects to settle the Purchase Contracts early, holders of Amortizing Notes (whether as holders of Units or separate Amortizing Notes) will have the right to require Issuer to repurchase some or all of their Amortizing
Notes for cash at a repurchase price per Amortizing Note equal to the principal amount of such Amortizing Note as of the repurchase date, plus accrued and unpaid interest on such principal amount from, and including, the immediately preceding
Installment Payment Date to, but not including, the repurchase date, calculated at a rate of 10.25% per annum. |
| --- | --- |
| Units Public Offering Price: | $50.00 per Unit $125,000,000 in the aggregate
(or $143,750,000 in the aggregate if the underwriters exercise their over-allotment option to purchase additional Units in full). |
| Underwriting Discount: | $1.50 per Unit $3,750,000 in the aggregate (or
$4,312,500 in the aggregate if the underwriters exercise their over-allotment option to purchase additional Units in full). |
| Use of Proceeds: | The net proceeds from the sale of Units in the Units Offering, after deducting the underwriting discounts and estimated offering expenses, will be approximately $120.3 million (or $138.5 million if the underwriters
exercise their over-allotment option to purchase additional Units in full). Issuer intends to use the net proceeds for general corporate purposes. See “Use of Proceeds” in the Preliminary Prospectus Supplement. |
| Joint Book-Running Managers: | BofA Securities, Inc. Barclays Capital
Inc. |
| Listing: | Issuer has applied to list the Units on the NYSE under the symbol “BKDT.” However, Issuer can give no assurance that the Units will be so listed. If the Units are approved for listing, Issuer expects trading on the NYSE to
begin within 30 calendar days after the Units are first issued. |

5

CUSIP for the Units: 112463 302
ISIN for the Units: US1124633025
CUSIP for the Purchase Contracts: 112463 401
ISIN for the Purchase Contracts: US1124634015
CUSIP for the Amortizing Notes: 112463 AD6
ISIN for the Amortizing Notes: US112463AD65

Issuer has filed a registration statement (including a prospectus and the Preliminary Prospectus Supplement) with the Securities and Exchange Commission (the “SEC”) for the Units Offering. Before you invest, you should read the prospectus in that registration statement, the Preliminary Prospectus Supplement and other documents Issuer has filed with the SEC for more complete information about Issuer and the Units Offering. You may get these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, Issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus if you request it by contacting (i) BofA Securities, Inc.; Attn: Prospectus Department, 200 North College Street, 3rd floor, Charlotte, NC 28255-0001, or by telephone at (800) 294-1322, or by emailing [email protected] or (ii) Barclays Capital Inc.; c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, or by telephone at (888) 603-5847, or by emailing [email protected].

This communication should be read in conjunction with the Preliminary Prospectus Supplement and the accompanying prospectus. The information in this communication supersedes the information in the Preliminary Prospectus Supplement and the accompanying prospectus to the extent inconsistent with the information in the Preliminary Prospectus Supplement and the accompanying prospectus.

ANY DISCLAIMERS OR OTHER NOTICES THAT MAY APPEAR BELOW ARE NOT APPLICABLE TO THIS COMMUNICATION AND SHOULD BE DISREGARDED. SUCH DISCLAIMERS OR OTHER NOTICES WERE AUTOMATICALLY GENERATED AS A RESULT OF THIS COMMUNICATION BEING SENT VIA BLOOMBERG OR ANOTHER EMAIL SYSTEM.

6

Talk to a Data Expert

Have a question? We'll get back to you promptly.